Innate Pharma【IPH】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.92

買値

1.92

売値

1.94

出来高

82,751

1.902 日の範囲 1.988

1.332 52 週間の範囲 2.79

時価総額

610.887M

前日終値

1.952

始値

1.958

時刻

1.92

最終取引時間

20:21:44

財務取引量

VWAP

平均取引量 (3 か月)

163,595

発行済株式数

318,170,508

配当利回り

PER

-81.51

1 株当たり利益 (EPS)

-0.02

歳入

61.64M

純利益

-7.57M

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.innate-pharma.com

本社

Marseille, Bouches-du-rhone, Fra

設立

Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker IPH. The last closing price for Innate Pharma was 1.95 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.332 € to 2.79 €.

Innate Pharma currently has 318,170,508 shares in issue. The market capitalisation of Innate Pharma is 621.07 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -81.51.

Innate Pharma annonce le traitement du premier patient dans l’essai de Phase 1 évaluant IPH4502, son conjugué anticorps-médicament ciblant Nectine-4, dans une sélection de tumeurs solides avancées

IPH4502 est un nouveau conjugué anticorps-médicament ciblant Nectine-4 et différencié à base d’exatecan, un inhibiteur de topoisomérase I, comme agent cytotoxique. Regulatory News: Innate Pharma...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.184	10.599078341	1.736	2.05	1.714	121709	1.88056457	DE
4	0.07	3.78378378378	1.85	2.05	1.702	108815	1.80358941	DE
12	0.42	28	1.5	2.49	1.332	163595	1.78094327	DE
26	-0.08	-4	2	2.49	1.332	100180	1.8156629	DE
52	-0.425	-18.1236673774	2.345	2.79	1.332	83706	2.00776673	DE
156	-1.456	-43.1279620853	3.376	3.8	1.332	130662	2.60343488	DE
260	-4.655	-70.7984790875	6.575	7.325	1.332	244820	3.75700891	DE

IPH - Frequently Asked Questions (FAQ)

What is the current Innate Pharma share price?

The current share price of Innate Pharma is 1.92 €

How many Innate Pharma shares are in issue?

Innate Pharma has 318,170,508 shares in issue

What is the market cap of Innate Pharma?

The market capitalisation of Innate Pharma is EUR 621.07M

What is the 1 year trading range for Innate Pharma share price?

Innate Pharma has traded in the range of 1.332 € to 2.79 € during the past year

What is the PE ratio of Innate Pharma?

The price to earnings ratio of Innate Pharma is -81.51

What is the cash to sales ratio of Innate Pharma?

The cash to sales ratio of Innate Pharma is 10.02

What is the reporting currency for Innate Pharma?

Innate Pharma reports financial results in EUR

What is the latest annual turnover for Innate Pharma?

The latest annual turnover of Innate Pharma is EUR 61.64M

What is the latest annual profit for Innate Pharma?

The latest annual profit of Innate Pharma is EUR -7.57M

What is the registered address of Innate Pharma?

The registered address for Innate Pharma is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009

What is the Innate Pharma website address?

The website address for Innate Pharma is www.innate-pharma.com

Which industry sector does Innate Pharma operate in?

Innate Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ALNMGNetMedia Group	2.34 € (67.14%)	15.45k
ALAGOEPango SA	0.383 € (20.44%)	4.94M
MLNMAMiguet Et Associes	0.08 € (14.29%)	415
ALMASMastrad	0.0262 € (13.91%)	10.99M
ALRGRRougier	17.80 € (10.56%)	3.69k
BIODSBiosynex DS	0.0079 € (-61.84%)	241.77k
ALNEVNeovacs	0.22 € (-24.14%)	83.32k
ALTROTronic s Microsystems	4.10 € (-23.36%)	39
ALVIOValerio Therapeutics	0.0618 € (-20.46%)	1.05M
TUVDSBio UV Group DS	0.04 € (-20.00%)	1.03M
ATOAtos SE	0.0021 € (0.00%)	55.07M
BCPBanco Comercial Portugues SA	0.4933 € (-0.22%)	23.04M
ALMASMastrad	0.0262 € (13.91%)	10.99M
ALNRGEnergisme SA	0.0034 € (6.25%)	6.06M
ALHPIHopium SA	0.003 € (3.45%)	5.02M